ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Biopsy Instruments and Kits Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-37S9630
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Cancer Biopsy Instruments and Kits Market Research Report 2022
BUY CHAPTERS

Global Cancer Biopsy Instruments and Kits Market Research Report 2025

Code: QYRE-Auto-37S9630
Report
March 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Qiagen NV
Illumina Inc
Becton Dickinson and Company
Myriad Genetics
Thermo Fisher Scientific Inc
Biocept
Angle plc
Hologic Inc
Lucence Diagnostics Pte. Ltd.
Danaher Corporation

Cancer Biopsy Instruments and Kits Market Size

The global market for Cancer Biopsy Instruments and Kits was valued at US$ 312 million in the year 2024 and is projected to reach a revised size of US$ 475 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Cancer Biopsy Instruments and Kits Market

Cancer Biopsy Instruments and Kits Market

Cancer biopsy instruments and kits are important tools for cancer diagnosis and treatment. They are used to extract tissue samples from suspected cancerous lesions for further analysis and testing. The global incidence of cancer continues to rise, which has led to an increasing demand for accurate and reliable diagnostic tools. Biopsy instruments and kits play a vital role in early detection and diagnosis of cancer, driving its demand.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cancer Biopsy Instruments and Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biopsy Instruments and Kits.
The Cancer Biopsy Instruments and Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Biopsy Instruments and Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Biopsy Instruments and Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cancer Biopsy Instruments and Kits Market Report

Report Metric Details
Report Name Cancer Biopsy Instruments and Kits Market
Accounted market size in year US$ 312 million
Forecasted market size in 2031 US$ 475 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company QIAGEN NV, Illumina, Inc., Becton, Dickinson and Company, Myriad Genetics, Thermo Fisher Scientific, Inc., BIOCEPT, INC., ANGLE plc, Hologic, Inc., Lucence Diagnostics Pte. Ltd., Danaher Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cancer Biopsy Instruments and Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cancer Biopsy Instruments and Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cancer Biopsy Instruments and Kits Market growing?

Ans: The Cancer Biopsy Instruments and Kits Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Cancer Biopsy Instruments and Kits Market size in 2031?

Ans: The Cancer Biopsy Instruments and Kits Market size in 2031 will be US$ 475 million.

Who are the main players in the Cancer Biopsy Instruments and Kits Market report?

Ans: The main players in the Cancer Biopsy Instruments and Kits Market are QIAGEN NV, Illumina, Inc., Becton, Dickinson and Company, Myriad Genetics, Thermo Fisher Scientific, Inc., BIOCEPT, INC., ANGLE plc, Hologic, Inc., Lucence Diagnostics Pte. Ltd., Danaher Corporation

What are the Application segmentation covered in the Cancer Biopsy Instruments and Kits Market report?

Ans: The Applications covered in the Cancer Biopsy Instruments and Kits Market report are Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Others

What are the Type segmentation covered in the Cancer Biopsy Instruments and Kits Market report?

Ans: The Types covered in the Cancer Biopsy Instruments and Kits Market report are Cancer Biopsy Instruments, Cancer Biopsy Kits

Recommended Reports

Biopsy Devices & Kits

Cancer Diagnostics

Cancer Screening & Testing

1 Cancer Biopsy Instruments and Kits Market Overview
1.1 Product Definition
1.2 Cancer Biopsy Instruments and Kits by Type
1.2.1 Global Cancer Biopsy Instruments and Kits Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cancer Biopsy Instruments
1.2.3 Cancer Biopsy Kits
1.3 Cancer Biopsy Instruments and Kits by Application
1.3.1 Global Cancer Biopsy Instruments and Kits Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Global Cancer Biopsy Instruments and Kits Market Size Estimates and Forecasts
1.4.1 Global Cancer Biopsy Instruments and Kits Revenue 2020-2031
1.4.2 Global Cancer Biopsy Instruments and Kits Sales 2020-2031
1.4.3 Global Cancer Biopsy Instruments and Kits Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cancer Biopsy Instruments and Kits Market Competition by Manufacturers
2.1 Global Cancer Biopsy Instruments and Kits Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cancer Biopsy Instruments and Kits Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cancer Biopsy Instruments and Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cancer Biopsy Instruments and Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cancer Biopsy Instruments and Kits, Product Type & Application
2.7 Global Key Manufacturers of Cancer Biopsy Instruments and Kits, Date of Enter into This Industry
2.8 Global Cancer Biopsy Instruments and Kits Market Competitive Situation and Trends
2.8.1 Global Cancer Biopsy Instruments and Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cancer Biopsy Instruments and Kits Players Market Share by Revenue
2.8.3 Global Cancer Biopsy Instruments and Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cancer Biopsy Instruments and Kits Market Scenario by Region
3.1 Global Cancer Biopsy Instruments and Kits Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cancer Biopsy Instruments and Kits Sales by Region: 2020-2031
3.2.1 Global Cancer Biopsy Instruments and Kits Sales by Region: 2020-2025
3.2.2 Global Cancer Biopsy Instruments and Kits Sales by Region: 2026-2031
3.3 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2020-2031
3.3.1 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2020-2025
3.3.2 Global Cancer Biopsy Instruments and Kits Revenue by Region: 2026-2031
3.4 North America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.4.1 North America Cancer Biopsy Instruments and Kits Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cancer Biopsy Instruments and Kits Sales by Country (2020-2031)
3.4.3 North America Cancer Biopsy Instruments and Kits Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.5.1 Europe Cancer Biopsy Instruments and Kits Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cancer Biopsy Instruments and Kits Sales by Country (2020-2031)
3.5.3 Europe Cancer Biopsy Instruments and Kits Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cancer Biopsy Instruments and Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Cancer Biopsy Instruments and Kits Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cancer Biopsy Instruments and Kits Sales by Region (2020-2031)
3.6.3 Asia Pacific Cancer Biopsy Instruments and Kits Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.7.1 Latin America Cancer Biopsy Instruments and Kits Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cancer Biopsy Instruments and Kits Sales by Country (2020-2031)
3.7.3 Latin America Cancer Biopsy Instruments and Kits Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cancer Biopsy Instruments and Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Cancer Biopsy Instruments and Kits Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cancer Biopsy Instruments and Kits Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cancer Biopsy Instruments and Kits Sales by Type (2020-2031)
4.1.1 Global Cancer Biopsy Instruments and Kits Sales by Type (2020-2025)
4.1.2 Global Cancer Biopsy Instruments and Kits Sales by Type (2026-2031)
4.1.3 Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2020-2031)
4.2 Global Cancer Biopsy Instruments and Kits Revenue by Type (2020-2031)
4.2.1 Global Cancer Biopsy Instruments and Kits Revenue by Type (2020-2025)
4.2.2 Global Cancer Biopsy Instruments and Kits Revenue by Type (2026-2031)
4.2.3 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2020-2031)
4.3 Global Cancer Biopsy Instruments and Kits Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cancer Biopsy Instruments and Kits Sales by Application (2020-2031)
5.1.1 Global Cancer Biopsy Instruments and Kits Sales by Application (2020-2025)
5.1.2 Global Cancer Biopsy Instruments and Kits Sales by Application (2026-2031)
5.1.3 Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2020-2031)
5.2 Global Cancer Biopsy Instruments and Kits Revenue by Application (2020-2031)
5.2.1 Global Cancer Biopsy Instruments and Kits Revenue by Application (2020-2025)
5.2.2 Global Cancer Biopsy Instruments and Kits Revenue by Application (2026-2031)
5.2.3 Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2020-2031)
5.3 Global Cancer Biopsy Instruments and Kits Price by Application (2020-2031)
6 Key Companies Profiled
6.1 QIAGEN NV
6.1.1 QIAGEN NV Company Information
6.1.2 QIAGEN NV Description and Business Overview
6.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio
6.1.5 QIAGEN NV Recent Developments/Updates
6.2 Illumina, Inc.
6.2.1 Illumina, Inc. Company Information
6.2.2 Illumina, Inc. Description and Business Overview
6.2.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
6.2.5 Illumina, Inc. Recent Developments/Updates
6.3 Becton, Dickinson and Company
6.3.1 Becton, Dickinson and Company Company Information
6.3.2 Becton, Dickinson and Company Description and Business Overview
6.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio
6.3.5 Becton, Dickinson and Company Recent Developments/Updates
6.4 Myriad Genetics
6.4.1 Myriad Genetics Company Information
6.4.2 Myriad Genetics Description and Business Overview
6.4.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio
6.4.5 Myriad Genetics Recent Developments/Updates
6.5 Thermo Fisher Scientific, Inc.
6.5.1 Thermo Fisher Scientific, Inc. Company Information
6.5.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.5.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
6.5.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.6 BIOCEPT, INC.
6.6.1 BIOCEPT, INC. Company Information
6.6.2 BIOCEPT, INC. Description and Business Overview
6.6.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio
6.6.5 BIOCEPT, INC. Recent Developments/Updates
6.7 ANGLE plc
6.7.1 ANGLE plc Company Information
6.7.2 ANGLE plc Description and Business Overview
6.7.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio
6.7.5 ANGLE plc Recent Developments/Updates
6.8 Hologic, Inc.
6.8.1 Hologic, Inc. Company Information
6.8.2 Hologic, Inc. Description and Business Overview
6.8.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
6.8.5 Hologic, Inc. Recent Developments/Updates
6.9 Lucence Diagnostics Pte. Ltd.
6.9.1 Lucence Diagnostics Pte. Ltd. Company Information
6.9.2 Lucence Diagnostics Pte. Ltd. Description and Business Overview
6.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio
6.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments/Updates
6.10 Danaher Corporation
6.10.1 Danaher Corporation Company Information
6.10.2 Danaher Corporation Description and Business Overview
6.10.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio
6.10.5 Danaher Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cancer Biopsy Instruments and Kits Industry Chain Analysis
7.2 Cancer Biopsy Instruments and Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cancer Biopsy Instruments and Kits Production Mode & Process Analysis
7.4 Cancer Biopsy Instruments and Kits Sales and Marketing
7.4.1 Cancer Biopsy Instruments and Kits Sales Channels
7.4.2 Cancer Biopsy Instruments and Kits Distributors
7.5 Cancer Biopsy Instruments and Kits Customer Analysis
8 Cancer Biopsy Instruments and Kits Market Dynamics
8.1 Cancer Biopsy Instruments and Kits Industry Trends
8.2 Cancer Biopsy Instruments and Kits Market Drivers
8.3 Cancer Biopsy Instruments and Kits Market Challenges
8.4 Cancer Biopsy Instruments and Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Qiagen NV
Illumina Inc
Becton Dickinson and Company
Myriad Genetics
Thermo Fisher Scientific Inc
Biocept
Angle plc
Hologic Inc
Lucence Diagnostics Pte. Ltd.
Danaher Corporation
List of Tables
 Table 1. Global Cancer Biopsy Instruments and Kits Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cancer Biopsy Instruments and Kits Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cancer Biopsy Instruments and Kits Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cancer Biopsy Instruments and Kits Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cancer Biopsy Instruments and Kits Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cancer Biopsy Instruments and Kits Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cancer Biopsy Instruments and Kits Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cancer Biopsy Instruments and Kits Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cancer Biopsy Instruments and Kits, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cancer Biopsy Instruments and Kits, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cancer Biopsy Instruments and Kits, Product Type & Application
 Table 12. Global Key Manufacturers of Cancer Biopsy Instruments and Kits, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cancer Biopsy Instruments and Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopsy Instruments and Kits as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cancer Biopsy Instruments and Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cancer Biopsy Instruments and Kits Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2020-2025)
 Table 19. Global Cancer Biopsy Instruments and Kits Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cancer Biopsy Instruments and Kits Sales Market Share by Region (2026-2031)
 Table 21. Global Cancer Biopsy Instruments and Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2020-2025)
 Table 23. Global Cancer Biopsy Instruments and Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2026-2031)
 Table 25. North America Cancer Biopsy Instruments and Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cancer Biopsy Instruments and Kits Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cancer Biopsy Instruments and Kits Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cancer Biopsy Instruments and Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cancer Biopsy Instruments and Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cancer Biopsy Instruments and Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cancer Biopsy Instruments and Kits Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cancer Biopsy Instruments and Kits Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cancer Biopsy Instruments and Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cancer Biopsy Instruments and Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cancer Biopsy Instruments and Kits Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cancer Biopsy Instruments and Kits Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cancer Biopsy Instruments and Kits Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cancer Biopsy Instruments and Kits Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cancer Biopsy Instruments and Kits Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cancer Biopsy Instruments and Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cancer Biopsy Instruments and Kits Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cancer Biopsy Instruments and Kits Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cancer Biopsy Instruments and Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cancer Biopsy Instruments and Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cancer Biopsy Instruments and Kits Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cancer Biopsy Instruments and Kits Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cancer Biopsy Instruments and Kits Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cancer Biopsy Instruments and Kits Sales (K Units) by Type (2020-2025)
 Table 51. Global Cancer Biopsy Instruments and Kits Sales (K Units) by Type (2026-2031)
 Table 52. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2020-2025)
 Table 53. Global Cancer Biopsy Instruments and Kits Sales Market Share by Type (2026-2031)
 Table 54. Global Cancer Biopsy Instruments and Kits Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cancer Biopsy Instruments and Kits Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2020-2025)
 Table 57. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Type (2026-2031)
 Table 58. Global Cancer Biopsy Instruments and Kits Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Cancer Biopsy Instruments and Kits Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Cancer Biopsy Instruments and Kits Sales (K Units) by Application (2020-2025)
 Table 61. Global Cancer Biopsy Instruments and Kits Sales (K Units) by Application (2026-2031)
 Table 62. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2020-2025)
 Table 63. Global Cancer Biopsy Instruments and Kits Sales Market Share by Application (2026-2031)
 Table 64. Global Cancer Biopsy Instruments and Kits Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cancer Biopsy Instruments and Kits Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2020-2025)
 Table 67. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Application (2026-2031)
 Table 68. Global Cancer Biopsy Instruments and Kits Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Cancer Biopsy Instruments and Kits Price (US$/Unit) by Application (2026-2031)
 Table 70. QIAGEN NV Company Information
 Table 71. QIAGEN NV Description and Business Overview
 Table 72. QIAGEN NV Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. QIAGEN NV Cancer Biopsy Instruments and Kits Product
 Table 74. QIAGEN NV Recent Developments/Updates
 Table 75. Illumina, Inc. Company Information
 Table 76. Illumina, Inc. Description and Business Overview
 Table 77. Illumina, Inc. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Illumina, Inc. Cancer Biopsy Instruments and Kits Product
 Table 79. Illumina, Inc. Recent Developments/Updates
 Table 80. Becton, Dickinson and Company Company Information
 Table 81. Becton, Dickinson and Company Description and Business Overview
 Table 82. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product
 Table 84. Becton, Dickinson and Company Recent Developments/Updates
 Table 85. Myriad Genetics Company Information
 Table 86. Myriad Genetics Description and Business Overview
 Table 87. Myriad Genetics Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Myriad Genetics Cancer Biopsy Instruments and Kits Product
 Table 89. Myriad Genetics Recent Developments/Updates
 Table 90. Thermo Fisher Scientific, Inc. Company Information
 Table 91. Thermo Fisher Scientific, Inc. Description and Business Overview
 Table 92. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product
 Table 94. Thermo Fisher Scientific, Inc. Recent Developments/Updates
 Table 95. BIOCEPT, INC. Company Information
 Table 96. BIOCEPT, INC. Description and Business Overview
 Table 97. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product
 Table 99. BIOCEPT, INC. Recent Developments/Updates
 Table 100. ANGLE plc Company Information
 Table 101. ANGLE plc Description and Business Overview
 Table 102. ANGLE plc Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. ANGLE plc Cancer Biopsy Instruments and Kits Product
 Table 104. ANGLE plc Recent Developments/Updates
 Table 105. Hologic, Inc. Company Information
 Table 106. Hologic, Inc. Description and Business Overview
 Table 107. Hologic, Inc. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hologic, Inc. Cancer Biopsy Instruments and Kits Product
 Table 109. Hologic, Inc. Recent Developments/Updates
 Table 110. Lucence Diagnostics Pte. Ltd. Company Information
 Table 111. Lucence Diagnostics Pte. Ltd. Description and Business Overview
 Table 112. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product
 Table 114. Lucence Diagnostics Pte. Ltd. Recent Developments/Updates
 Table 115. Danaher Corporation Company Information
 Table 116. Danaher Corporation Description and Business Overview
 Table 117. Danaher Corporation Cancer Biopsy Instruments and Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Danaher Corporation Cancer Biopsy Instruments and Kits Product
 Table 119. Danaher Corporation Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Cancer Biopsy Instruments and Kits Distributors List
 Table 123. Cancer Biopsy Instruments and Kits Customers List
 Table 124. Cancer Biopsy Instruments and Kits Market Trends
 Table 125. Cancer Biopsy Instruments and Kits Market Drivers
 Table 126. Cancer Biopsy Instruments and Kits Market Challenges
 Table 127. Cancer Biopsy Instruments and Kits Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cancer Biopsy Instruments and Kits
 Figure 2. Global Cancer Biopsy Instruments and Kits Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Biopsy Instruments and Kits Market Share by Type: 2024 & 2031
 Figure 4. Cancer Biopsy Instruments Product Picture
 Figure 5. Cancer Biopsy Kits Product Picture
 Figure 6. Global Cancer Biopsy Instruments and Kits Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cancer Biopsy Instruments and Kits Market Share by Application: 2024 & 2031
 Figure 8. Breast Cancer
 Figure 9. Colorectal Cancer
 Figure 10. Cervical Cancer
 Figure 11. Lung Cancer
 Figure 12. Others
 Figure 13. Global Cancer Biopsy Instruments and Kits Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cancer Biopsy Instruments and Kits Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Cancer Biopsy Instruments and Kits Sales (2020-2031) & (K Units)
 Figure 16. Global Cancer Biopsy Instruments and Kits Average Price (US$/Unit) & (2020-2031)
 Figure 17. Cancer Biopsy Instruments and Kits Report Years Considered
 Figure 18. Cancer Biopsy Instruments and Kits Sales Share by Manufacturers in 2024
 Figure 19. Global Cancer Biopsy Instruments and Kits Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Cancer Biopsy Instruments and Kits Players: Market Share by Revenue in Cancer Biopsy Instruments and Kits in 2024
 Figure 21. Cancer Biopsy Instruments and Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Cancer Biopsy Instruments and Kits Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Cancer Biopsy Instruments and Kits Sales Market Share by Country (2020-2031)
 Figure 24. North America Cancer Biopsy Instruments and Kits Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Cancer Biopsy Instruments and Kits Sales Market Share by Country (2020-2031)
 Figure 28. Europe Cancer Biopsy Instruments and Kits Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Cancer Biopsy Instruments and Kits Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Cancer Biopsy Instruments and Kits Revenue Market Share by Region (2020-2031)
 Figure 36. China Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Cancer Biopsy Instruments and Kits Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Cancer Biopsy Instruments and Kits Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Cancer Biopsy Instruments and Kits Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Cancer Biopsy Instruments and Kits Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Cancer Biopsy Instruments and Kits by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Cancer Biopsy Instruments and Kits by Type (2020-2031)
 Figure 58. Global Cancer Biopsy Instruments and Kits Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Cancer Biopsy Instruments and Kits by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Cancer Biopsy Instruments and Kits by Application (2020-2031)
 Figure 61. Global Cancer Biopsy Instruments and Kits Price (US$/Unit) by Application (2020-2031)
 Figure 62. Cancer Biopsy Instruments and Kits Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Biopsy Equipment Market Research Report 2024
Aspiration and Biopsy Needles Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aspiration Biopsy Needle Market Research Report 2024
Global Prostate Biopsy Needle Market Research Report 2025
Global Disposable Core Biopsy Instrument Kit Market Research Report 2025
Global Cancer Test Kit Market Insights Forecast to 2030
Global Pathology Instruments Market Research Report 2024
Global Reusable Core Biopsy Instrument Market Research Report 2025
Global Biopsy Forceps Market Research Report 2024
Global Cancer Biopsy Market Size Status and Forecast 2021 2027
Global Breast Biopsy Devices Market Insights Forecast to 2025
Global Tumor Liquid Biopsy Kit Market Research Report 2024
Global Tumor Cell Isolation Kits Market Research Report 2025
Global Disposable Puncture Biopsy Needle Market Research Report 2025
Global Bladder Cancer Kit Market Research Report 2024
Bladder Cancer Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bronchial Biopsy Devices Market Research Report 2025
Smart Biopsy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bone Marrow Aspiration Biopsy Needle Kit Market Research Report 2024
Global Orthopedic Biopsy Sampler Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions